THE DEAL, AT A GLANCE
3/4 reviewedAnaconda Biomed
Anaconda Biomed
Medical devices: funnel catheters that remove stroke-causing clots and restore brain blood flow.
Anaconda Biomed raised $56M, announced 2026-09-2301What it doesMedical devices: funnel catheters that remove stroke-causing clots and restore brain blood flow.Source-grounded · automated review · Explore ↗
Checked 2026-10-04 · Review due 2026-10-11
Read supporting source ↗Anaconda’s proprietary Funnel Catheter platform…
02Who is involvedOmega Funds led; FOCO joined; Asabys, Ysios and CDTI continued as participating investors.Source-grounded · automated review · Explore ↗
03What happenedAnaconda Biomed raised $56M, announced 2026-09-23From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersFunding supports catheter development and a pivotal clinical study for stroke clot-removal treatment.Interpretation · Explore ↗
Checked 2026-10-04 · Review due 2026-10-11
Read supporting source ↗Proceeds will support product development…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
Anaconda Biomed · Financing Record
Explore source-linked visual explanations for Anaconda Biomed. Unsupported claims are withheld while source review continues.
Record 12665 · Recorded date: 2026-09-23
Explore company records →